Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA warns of severe joint pain risk with DPP-4 diabetes drugs
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
Submitted by
admin
on August 28, 2015 - 5:52pm
Source:
Yahoo/Reuters
News Tags:
FDA
diabetes
joint pain
DPP-4 inhibitor
Merck
Januvia
Onglyza
AstraZeneca
Takeda
Boehringer Ingelheim
Headline:
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
Do Not Allow Advertisers to Use My Personal information
